Mark Anthony McCamish's Net Worth
$5.39 Million
Who is Mark Anthony McCamish?
Mark Anthony McCamish has an estimated net worth of $5.39 Million. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, AVADEL PHARMACEUTICALS PLC, Vincera Pharma, Inc., Rafael Holdings, Inc., Forty Seven, Inc., and PDL BIOPHARMA, INC..
SEC CIK
Mark Anthony McCamish's CIK is 0001390798
Past Insider Trading and Trends
2019 was Mark Anthony McCamish's most active year for acquiring shares with 14 total transactions. Mark Anthony McCamish's most active month to acquire stocks was the month of December. 2019 was Mark Anthony McCamish's most active year for disposing of shares, totalling 21 transactions. Mark Anthony McCamish's most active month to dispose stocks was the month of March. 2020 saw Mark Anthony McCamish paying a total of $1,132,850.93 for 299,904 shares, this is the most they've acquired in one year. In 2020 Mark Anthony McCamish cashed out on 1,423,282 shares for a total of $3,108,504.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FACET BIOTECH CORP No price found
Sr. VP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| -11.88% | -1.78K |
$6.56 | -$11,676.80 | 13.2K |
Feb 21
| |||
Form 4
| +481.75% | 12.4K |
—
|
—
| 14.98K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVADEL PHARMACEUTICALS PLC (AVDL) Snapshot price: $14.765
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -52.81% | -75.00K |
$14.53 | -$1,089,750.00 | 67.03K |
Scheduled
|
Dec 28
| ||
Form 4
| -16.94% | -28.98K |
$14.93 | -$432,614.13 | 142.03K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
∞
| 171K |
$5.76 | $985,218.78 | 171K |
Sep 16 - Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vincera Pharma, Inc. (VINC) Snapshot price: $1.4001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rafael Holdings, Inc. (RFL) Snapshot price: $1.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +84.87% | 27.66K |
$1.81 | $50,055.55 | 60.24K |
Jan 5
| |||
Form 4
| +502.11% | 27.17K |
$1.84 | $50,000.16 | 32.59K |
Jan 5
| |||
Form 4
|
∞
| 5.41K |
$5.39 | $29,170.68 | 5.41K |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forty Seven, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.59K |
—
|
—
|
0
|
Apr 7
| |||
Form 4
| -93.21% | -63.06K |
$50.15 | -$2,960,871.85 | 4.59K |
Mar 16 - Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
$7.95 | -$50,359.08 | 60.72K |
Scheduled
|
Jun 25
| ||
Form 4
|
—
|
0
|
$7.96 | -$51,096.81 | 60.72K |
Scheduled
|
Jun 20
| ||
Form 4
|
—
|
0
|
$8.49 | -$119,164.43 | 60.72K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$11.50 | -$218,493.00 | 60.72K |
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$11.51 | -$218,839.50 | 60.72K |
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
$9.94 | -$166,781.30 | 60.72K |
Scheduled
|
Feb 19 - Feb 20
| ||
Form 4
| +572.27% | 51.69K |
$4.88 | $252,361.78 | 60.72K |
Jan 25
| |||
Form 4
|
—
|
0
|
$9.74 | -$194,242.00 | 9.03K |
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
$10.39 | -$132,215.87 | 9.03K |
Scheduled
|
Dec 26
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||